These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 4230957

  • 1. Fibrinolytic system in patients with hypertensive cardiovascular disease.
    Prokopowicz J, Worowski K, Poplawski A, Gabryelewicz A, Niewiarowski S.
    Thromb Diath Haemorrh; 1967 Feb 28; 17(1-2):1-7. PubMed ID: 4230957
    [No Abstract] [Full Text] [Related]

  • 2. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K, Prokopowicz J, Gabryelewicz A.
    Haematologia (Budap); 1970 Feb 28; 4(3):399-403. PubMed ID: 4256949
    [No Abstract] [Full Text] [Related]

  • 3. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM, MacCarthy EP, Glas-Greenwalt P, Clyne DH, Pollak VE.
    J Hypertens Suppl; 1984 Dec 28; 2(3):S175-8. PubMed ID: 6242555
    [Abstract] [Full Text] [Related]

  • 4. [Fibrinolytic system of blood in patients with hypertensive disease].
    Fatkhullaev IF, Agapova LA.
    Ter Arkh; 1974 Dec 28; 46(6):24-7. PubMed ID: 4279461
    [No Abstract] [Full Text] [Related]

  • 5. Fibrinolytic system in normotensive subjects and hypertensive patients.
    Armas-Hernández MJ, Hernández-Hernández R, Armas-Padilla MC, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero-Pajuelo J, Israili ZH, Valasco M.
    Am J Ther; 2007 Dec 28; 14(2):177-82. PubMed ID: 17414587
    [Abstract] [Full Text] [Related]

  • 6. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
    Stein D, Heins M, Schoebel FC, Pels K, Jax TW, Stiegler H, Reinauer H, Strauer BE, Leschke M.
    Thromb Haemost; 1997 May 28; 77(5):970-4. PubMed ID: 9184412
    [Abstract] [Full Text] [Related]

  • 7. [Comparative analysis of disorders of cerebral circulation in renal arterial hypertension and hypertensive disease].
    Lebedeva NV, Gulevskaia TS.
    Klin Med (Mosk); 1984 Jun 28; 62(6):70-6. PubMed ID: 6471802
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of diet therapy on status of hemocoagulation and fibrinolysis in type 2 diabetes patients].
    Alekseeva RI, Meshcheriakova VA, Sharafetdinov KhKh, Plotnikova OA, Liutova LV, Karabasova MA, Andreenko GV.
    Vopr Pitan; 2003 Jun 28; 72(5):18-21. PubMed ID: 14619610
    [Abstract] [Full Text] [Related]

  • 9. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK, Stavroulakis G, Papadopoulos DP, Krespi P, Hatzizacharias A, Zilidis A, Tsoukala C, Votteas VE.
    Drugs Exp Clin Res; 2004 Jun 28; 30(3):125-32. PubMed ID: 15366789
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic and renin activity in renal vein blood of patients with renovascular hypertension.
    Nowak A, Kokot F, Czekala Z, Dosiak J, Kuska J.
    Thromb Diath Haemorrh; 1969 Feb 28; 21(1):12-9. PubMed ID: 4237621
    [No Abstract] [Full Text] [Related]

  • 11. Effect of fibrinolysis on adhesion and aggregation of human platelets.
    Cronberg S.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):474-82. PubMed ID: 4236822
    [No Abstract] [Full Text] [Related]

  • 12. [Fibrinolytic and peripheral serotonergic system in patients with glomerulonephritis].
    Małyszko J, Małyszko J, Myśliwiec M, Pawlak D, Buczko W.
    Przegl Lek; 1995 Jul 31; 52(9):428-30. PubMed ID: 8834642
    [Abstract] [Full Text] [Related]

  • 13. Impact of cilazapril on fibrinolytic system in hypertensive patients.
    Hosgor I, Ahmad S.
    Blood Coagul Fibrinolysis; 2008 Jan 31; 19(1):101-5. PubMed ID: 18180626
    [Abstract] [Full Text] [Related]

  • 14. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
    Janody D, Droulle C, Adjizian JC, Ostermann G, Poynard JP, Jeunehomme G, Leutenegger M, Potron G.
    J Mal Vasc; 1982 Jan 31; 7(3):221-4. PubMed ID: 6815291
    [Abstract] [Full Text] [Related]

  • 15. [So-called essential renal hematuria and fibrinolytic enzyme system].
    Manabe H.
    Hinyokika Kiyo; 1971 May 31; 17(5):314-29. PubMed ID: 4253913
    [No Abstract] [Full Text] [Related]

  • 16. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 31; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 17. White coat hypertension and haemostatic/fibrinolytic balance disorders.
    Makris T, Stavroulakis G, Papadopoulos D, Paizis I, Krespi P, Tsoukala C, Hatzizacharias A, Votteas V.
    Eur Cytokine Netw; 2006 Jun 31; 17(2):137-41. PubMed ID: 16840033
    [Abstract] [Full Text] [Related]

  • 18. [The indices of the fibrinolysis, blood coagulation and lipid transport systems in hypertension patients].
    Sorokin EV, Karpov IuA, Dobrovol'skiĭ AB, Vil'chinskaia MIu, Panchenko EP, Titaeva EV, Kagan-Ponomarev MIa.
    Ter Arkh; 1996 Jun 31; 68(9):19-23. PubMed ID: 9005605
    [Abstract] [Full Text] [Related]

  • 19. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ, Peabody RA, Wu KT, Devaraj KT, Eckert C.
    J Cardiovasc Surg (Torino); 1974 Jun 31; 15(6):651-4. PubMed ID: 4281429
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of euphylline on the fibrinolytic system of blood in patients with atherosclerosis and hypertensive disease].
    Bogomolova EK, Sukhanov AA, Iastrebova LP, Iampol'skaia LA.
    Klin Med (Mosk); 1975 Apr 31; 53(4):51-3. PubMed ID: 1152372
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.